Drug intelligence / Profile preview

J5dLPS + OMP

Development stage
Phase 1
Lead developer
Walter Reed Army Institute of Research
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

J5dLPS + OMP is a novel vaccine construct designed to elicit broad-spectrum immunity against Gram-negative bacteria. It consists of detoxified, O-polysaccharide side chain-deficient lipopolysaccharide (J5 dLPS) derived from Escherichia coli 0111:B4 (J5 mutant), non-covalently complexed with the outer membrane protein (OMP) of Neisseria meningitidis group B. The removal of the immunodominant O side chain exposes highly conserved core glycolipid epitopes shared among Gram-negative bacteria. The Neisseria-derived OMP acts as a Toll-like receptor 2 ligand and stabilizes the glycolipid structure. Immunization with this construct induces high-titer polyclonal antibodies targeting these conserved core regions, promoting clearance of diverse Gram-negative pathogens and providing protection in animal models against lethal infections such as Francisella tularensis and Klebsiella pneumoniae. In veterinary applications, immunization in cows leads to high titers of anti-endotoxin antibodies that are transferred into colostrum, potentially reducing endotoxemia-related inflammation in recipients[1][2].

Other names
detoxified J5 LPS/group B meningococcal outer membrane protein vaccinedetoxified endotoxin vaccine
02

Targets

TLR2 (Toll-like Receptor 2)Neisseria meningitidis serogroup B outer membrane antigens

Beyond the preview

Go deeper on J5dLPS + OMP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on J5dLPS + OMP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call